AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46
BOTULINUM TOXIN TYPE-A FOR FACIAL REJUVENATION - UNITED-STATES AND UNITED-KINGDOM PERSPECTIVES
Authors: LOWE NJ
Citation: Nj. Lowe, BOTULINUM TOXIN TYPE-A FOR FACIAL REJUVENATION - UNITED-STATES AND UNITED-KINGDOM PERSPECTIVES, Dermatologic surgery, 24(11), 1998, pp. 1216-1218
A COMPARISON OF THE EFFICACY AND SAFETY OF THE COMBINATION MOMETASONEFUROATE 0.1-PERCENT SALICYLIC-ACID 5-PERCENT OINTMENT WITH EACH OF ITS COMPONENTS IN PSORIASIS
Authors: KATZ HI TANNER DJ CUFFIE CA BRODY NI GARCIA CJ LOWE NJ MEDANSKY RS ROTH HL SHAVIN JS SWINYER LJ
Citation: Hi. Katz et al., A COMPARISON OF THE EFFICACY AND SAFETY OF THE COMBINATION MOMETASONEFUROATE 0.1-PERCENT SALICYLIC-ACID 5-PERCENT OINTMENT WITH EACH OF ITS COMPONENTS IN PSORIASIS, Journal of dermatological treatment, 9(3), 1998, pp. 151-156
ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL
Authors: SCHER RK BRENEMAN D RICH P SAVIN RC FEINGOLD DS KONNIKOV N SHUPACK JL PINNELL S LEVINE N LOWE NJ ALY R ODOM RB GREER DL MORMAN MR BUCKO AD TSCHEN EH ELEWSKI BE SMITH EB
Citation: Rk. Scher et al., ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 77-86
ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL
Authors: DRAKE L BABEL D STEWART DM RICH P LING MR BRENEMAN D SCHER RK MARTIN AG PARISER DM PARISER RJ ELLIS CN KANG SW KATZ HI MCDONALD CJ MUGLIA J SAVIN RC WEBSTER G ELEWSKI BE LEYDEN JJ BUCKO AD TSCHEN EH HANIFIN JM MORMAN MR SHUPACK JL LEVINE N LOWE NJ BERGFELD WF CAMISA C FEINGOLD DS KONNIKOV N ODOM RB ALY R GREER DL
Citation: L. Drake et al., ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 87-94
PHARMACOKINETICS OF 3 DOSES OF ONCE-WEEKLY FLUCONAZOLE (150, 300, AND450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL
Authors: RICH P SCHER RK BRENEMAN D SAVIN RC FEINGOLD DS KONNIKOV N SHUPACK JL PINNELL S LEVINE N LOWE NJ ALY R ODOM RB GREER DL MORMAN MR BUCKO AD TSCHEN EH ELEWSKI BE SMITH EB HILBERT J
Citation: P. Rich et al., PHARMACOKINETICS OF 3 DOSES OF ONCE-WEEKLY FLUCONAZOLE (150, 300, AND450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 103-109
PHARMACOKINETICS OF 3 ONCE-WEEKLY DOSAGES OF FLUCONAZOLE (150, 300, OR 450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL
Authors: SAVIN RC DRAKE L BABEL D STEWART DM RICH P LING MR BRENEMAN D SCHER RK MARTIN AG PARISER DM PARISER RJ ELLIS CN KANG SW FRIEDMAN D KATZ HI MCDONALD CJ MUGLIA J WEBSTER G ELEWSKI BE LEYDEN JJ BUCKO AD TSCHEN EH HANIFIN JM MORMAN MR SHUPACK JL LEVINE N LOWE NJ BERGFELD WF CAMISA C FEINGOLD DS KONNIKOV N ODOM RB ALY R GREER DL HILBERT J
Citation: Rc. Savin et al., PHARMACOKINETICS OF 3 ONCE-WEEKLY DOSAGES OF FLUCONAZOLE (150, 300, OR 450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 110-116
ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS
Authors: LEBWOHL M AST E CALLEN JP CULLEN SI HONG SR KULPSHORTEN CL LOWE NJ PHILLIPS TJ ROSEN T WOLF DI QUELL JM SEFTON J LUE JC GIBSON JR CHANDRARATNA RAS
Citation: M. Lebwohl et al., ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS, Journal of the American Academy of Dermatology, 38(5), 1998, pp. 705-711
AZELAIC ACID 20-PERCENT CREAM IN THE TREATMENT OF FACIAL HYPERPIGMENTATION IN DARKER-SKINNED PATIENTS
Authors: LOWE NJ RIZK D GRIMES P BILLIPS M PINCUS S
Citation: Nj. Lowe et al., AZELAIC ACID 20-PERCENT CREAM IN THE TREATMENT OF FACIAL HYPERPIGMENTATION IN DARKER-SKINNED PATIENTS, Clinical therapeutics, 20(5), 1998, pp. 945-959
AZELAIC ACID AND GLYCOLIC ACID COMBINATION THERAPY FOR FACIAL HYPERPIGMENTATION IN DARKER-SKINNED PATIENTS - A CLINICAL COMPARISON WITH HYDROQUINONE
Authors: KAKITA LS LOWE NJ
Citation: Ls. Kakita et Nj. Lowe, AZELAIC ACID AND GLYCOLIC ACID COMBINATION THERAPY FOR FACIAL HYPERPIGMENTATION IN DARKER-SKINNED PATIENTS - A CLINICAL COMPARISON WITH HYDROQUINONE, Clinical therapeutics, 20(5), 1998, pp. 960-970
A RANDOMIZED, DOUBLE-BLIND-STUDY COMPARING THE EFFICACY, SAFETY AND OPTIMAL DOSE OF 2 FORMULATIONS OF CYCLOSPORINE, NEORAL AND SANDIMMUN, IN PATIENTS WITH SEVERE PSORIASIS
Authors: KOO J ABRAMS B ALBRECHT G ALTMEYER P BAHMER FA BELAICH S BERTHJONES J BJERKE JR BOS JD BRAATHEN L BURG G BURROWS D CLAUDY A DRAKE LA DUBERTRET L ENGST R ETTELT MI FRENK E FROSCH PJ GANSLANDT J GOOS M GRAHAMBROWN RAC GUILHOU JJ HAUSTEIN UF HELLAND S HUTCHINSON K JACOBI H JUNG EG KANG S KIND P KNOP J LOWE NJ LUGER T MAHRLE G MARKS R MEFFERT H MEYER J MORK NJ MROWIETZ U NEUMANN HAM OLSEN EA ROGERS S RUZICKA T SCHMIDT AG SCHOPF E SHUPACK JL STARINK TM TIO D VANVLOTEN WA VERMEER BJ WOLLINA U
Citation: J. Koo et al., A RANDOMIZED, DOUBLE-BLIND-STUDY COMPARING THE EFFICACY, SAFETY AND OPTIMAL DOSE OF 2 FORMULATIONS OF CYCLOSPORINE, NEORAL AND SANDIMMUN, IN PATIENTS WITH SEVERE PSORIASIS, British journal of dermatology, 139(1), 1998, pp. 88-95
THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS
Authors: KRUEGER GG DRAKE LA ELIAS PM LOWE NJ GUZZO C WEINSTEIN GD LEWKAYA DA LUE JC SEFTON J CHANDRARATNA RAS
Citation: Gg. Krueger et al., THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS, Archives of dermatology, 134(1), 1998, pp. 57-60
PHOTO(CHEMO)THERAPY - GENERAL-PRINCIPLES
Authors: LOWE NJ CHIZHEVSKY V GABRIEL H
Citation: Nj. Lowe et al., PHOTO(CHEMO)THERAPY - GENERAL-PRINCIPLES, Clinics in dermatology, 15(5), 1997, pp. 745-752
LONG-TERM LOW-DOSE CYCLOSPORINE THERAPY FOR PSORIASIS - REPLY
Authors: LOWE NJ
Citation: Nj. Lowe, LONG-TERM LOW-DOSE CYCLOSPORINE THERAPY FOR PSORIASIS - REPLY, Journal of the American Academy of Dermatology, 37(4), 1997, pp. 671-672
TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT
Authors: WEINSTEIN GD KRUEGER GG LOWE NJ DUVIC M FRIEDMAN DJ JEGASOTHY BV JORIZZO JL SHMUNES E TSCHEN EH LEWKAYA DA LUE JC SEFTON J GIBSON JR CHANDRARATNA RAS
Citation: Gd. Weinstein et al., TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT, Journal of the American Academy of Dermatology, 37(1), 1997, pp. 85-92
INITIATING NEORAL(R) THERAPY
Authors: LOWE NJ
Citation: Nj. Lowe, INITIATING NEORAL(R) THERAPY, International journal of dermatology, 36, 1997, pp. 30-33
INFRAORBITAL PIGMENTED SKIN - PRELIMINARY-OBSERVATIONS OF LASER THERAPY (VOL 21, PG 767, 1995)
Authors: LOWE NJ WIEDER JM SHORR N BOXRUD C SAUCER D CHALET M
Citation: Nj. Lowe et al., INFRAORBITAL PIGMENTED SKIN - PRELIMINARY-OBSERVATIONS OF LASER THERAPY (VOL 21, PG 767, 1995), Dermatologic surgery, 22(5), 1996, pp. 486-486
LONG-TERM LOW-DOSE CYCLOSPORINE THERAPY FOR SEVERE PSORIASIS - EFFECTS ON RENAL-FUNCTION AND STRUCTURE
Authors: LOWE NJ WIEDER JM ROSENBACH A JOHNSON K KUNKEL R BAINBRIDGE C BOURGET T DIMOV I SIMPSON K GLASS E GRABIE MT
Citation: Nj. Lowe et al., LONG-TERM LOW-DOSE CYCLOSPORINE THERAPY FOR SEVERE PSORIASIS - EFFECTS ON RENAL-FUNCTION AND STRUCTURE, Journal of the American Academy of Dermatology, 35(5), 1996, pp. 710-719
BOTULINUM-A EXOTOXIN FOR GLABELLAR FOLDS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN ELECTROMYOGRAPHIC INJECTION TECHNIQUE
Authors: LOWE NJ MAXWELL A HARPER H
Citation: Nj. Lowe et al., BOTULINUM-A EXOTOXIN FOR GLABELLAR FOLDS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN ELECTROMYOGRAPHIC INJECTION TECHNIQUE, Journal of the American Academy of Dermatology, 35(4), 1996, pp. 569-572
TOPICAL CALCIPOTRIENE HAS NO SHORT-TERM EFFECT ON CALCIUM AND BONE METABOLISM OF PATIENTS WITH PSORIASIS
Authors: GUZZO C LAZARUS G GOFFE BS KATZ HI LOWE NJ PINCUS SH
Citation: C. Guzzo et al., TOPICAL CALCIPOTRIENE HAS NO SHORT-TERM EFFECT ON CALCIUM AND BONE METABOLISM OF PATIENTS WITH PSORIASIS, Journal of the American Academy of Dermatology, 34(3), 1996, pp. 429-433
INFRAORBITAL PIGMENTED SKIN - PRELIMINARY-OBSERVATIONS OF LASER THERAPY
Authors: LOWE NJ WIEDER JM SHORR N BOXRUD C SAUCER D CHALET M
Citation: Nj. Lowe et al., INFRAORBITAL PIGMENTED SKIN - PRELIMINARY-OBSERVATIONS OF LASER THERAPY, Dermatologic surgery, 21(9), 1995, pp. 767-770
LASER SKIN RESURFACING - PRETREATMENT AND POSTTREATMENT GUIDELINES
Authors: LOWE NJ LASK G GRIFFIN ME
Citation: Nj. Lowe et al., LASER SKIN RESURFACING - PRETREATMENT AND POSTTREATMENT GUIDELINES, Dermatologic surgery, 21(12), 1995, pp. 1017-1019
SKIN RESURFACING WITH THE ULTRAPULSE CARBON-DIOXIDE LASER - OBSERVATIONS ON 100 PATIENTS
Authors: LOWE NJ LASK G GRIFFIN ME MAXWELL A LOWE P QUILADA F
Citation: Nj. Lowe et al., SKIN RESURFACING WITH THE ULTRAPULSE CARBON-DIOXIDE LASER - OBSERVATIONS ON 100 PATIENTS, Dermatologic surgery, 21(12), 1995, pp. 1025-1029
LASER RESURFACING IN PIGMENTED SKIN
Authors: HO C NGUYEN Q LOWE NJ GRIFFIN ME LASK G
Citation: C. Ho et al., LASER RESURFACING IN PIGMENTED SKIN, Dermatologic surgery, 21(12), 1995, pp. 1035-1037
SYSTEMIC RETINOIDS FOR PSORIASIS
Authors: WIEDER JM LOWE NJ
Citation: Jm. Wieder et Nj. Lowe, SYSTEMIC RETINOIDS FOR PSORIASIS, Dermatologic clinics, 13(4), 1995, pp. 891
LOW-DOSES OF REPETITIVE ULTRAVIOLET A INDUCE MORPHOLOGIC CHANGES IN HUMAN SKIN
Authors: LOWE NJ MEYERS DP WIEDER JM LUFTMAN D BORGET T LEHMAN MD JOHNSON AW SCOTT IR
Citation: Nj. Lowe et al., LOW-DOSES OF REPETITIVE ULTRAVIOLET A INDUCE MORPHOLOGIC CHANGES IN HUMAN SKIN, Journal of investigative dermatology, 105(6), 1995, pp. 739-743
Risultati: 1-25 | 26-46